Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection

Published:2021-06 Issue:6 Volume:24 Page:102555
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Steele Lynette,Mannion Aarren J.^ORCID,Shaw Gary^ORCID,Maclennan Kenneth A.,Cook Graham P.^ORCID,Rudd Christopher E.,Taylor Alison

Funder

Wellcome Trust

Cancer Research UK

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference34 articles.

1. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells;Appleman;J. Immunol.,2002

2. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3;Beals;Science,1997

3. Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3;Beurel;J. Immunol.,2013

4. Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells;Beurel;J. Immunol.,2011

5. T-cell development is regulated by the coordinated function of proximal and distal Lck promoters active at different developmental stages;Chiang;Eur. J. Immunol.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression;Cancer Immunology, Immunotherapy;2024-01

2. Human colorectal cancer: upregulation of the adaptor protein Rai in TILs leads to cell dysfunction by sustaining GSK-3 activation and PD-1 expression;2023-06-26

3. Effects of different dietary starch sources on growth and glucose metabolism of geese;Poultry Science;2023-02

4. Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells;Journal of Hematology & Oncology;2022-09-14

5. Combination Approaches to Target PD-1 Signaling in Cancer;Frontiers in Immunology;2022-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3